"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."

During the past decade, Asklepios Klinik St. Georg conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 36 clinical trials were completed, i.e. on average, 65.5% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 22 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asklepios Klinik St. Georg" #1 sponsor was "Abbott Medical Devices" with 14 trials, followed by "Edwards Lifesciences" with 9 trials sponsored, "German CLL Study Group" with 8 trials sponsored, "Asklepios proresearch" with 7 trials sponsored and "Celgene" with 7 trials sponsored. Other sponsors include 108 different institutions and companies that sponsored additional 89 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Klinik St. Georg" #1 collaborator was "Medtronic" with 5 trials as a collaborator, "Abbott Medical Devices" with 4 trials as a collaborator, "Medstar Health Research Institute" with 4 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Asklepios Klinik St. Georg" are "Atrial Fibrillation" (15 trials), "Heart Failure" (10 trials), "Chronic Lymphocytic Leukemia" (7 trials), "Aortic Valve Stenosis" (5 trials) and "HIV Infections" (5 trials). Many other conditions were trialed in "Asklepios Klinik St. Georg" in a lesser frequency.

Most popular intervention types in "Asklepios Klinik St. Georg" are "Drug" (67 trials), "Device" (52 trials), "Procedure" (27 trials), "Biological" (15 trials) and "Other" (14 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (9 trials), "Placebo" (7 trials), "rituximab" (7 trials), "filgrastim" (6 trials) and "peripheral blood stem cell transplantation" (6 trials). Other intervention names were less common.

The vast majority of trials in "Asklepios Klinik St. Georg" are 157 trials for "All" genders.

Currently, there are NaN active trials in "Asklepios Klinik St. Georg". 1 are not yet recruiting, 18 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 102 completed trials in Asklepios Klinik St. Georg, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Asklepios Klinik St. Georg, 4 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 44 trials that are defined as “Not Applicable".